Prof Jordi Gracia-Sancho, Barcelona, discusses the need to develop new therapeutic approaches that target more than one molecular pathway for chronic liver disease.

SUBSCRIBE & FOLLOW US

Subscribe Our Newsletter To Get the Lastest Updates